Low Dose IL2 Immunotherapy in AD

Clinical trial NCT05821153 · COMPLETED

Trial details

NCT number: NCT05821153
Sponsor: The Methodist Hospital Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2019-06-19
Primary completion: 2022-04-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.